BI Asset Management Fondsmaeglerselskab A S Buys 9,409 Shares of Synopsys, Inc. $SNPS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

BI Asset Management Fondsmaeglerselskab A S raised its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 11.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 91,278 shares of the semiconductor company's stock after purchasing an additional 9,409 shares during the period. BI Asset Management Fondsmaeglerselskab A S owned approximately 0.06% of Synopsys worth $39,145,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ameriflex Group Inc. acquired a new position in shares of Synopsys in the fourth quarter valued at approximately $29,000. Cornerstone Planning Group LLC boosted its holdings in shares of Synopsys by 275.0% in the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after buying an additional 44 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of Synopsys by 441.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock valued at $28,000 after buying an additional 53 shares during the period. Cloud Capital Management LLC acquired a new position in shares of Synopsys in the first quarter valued at approximately $36,000. Finally, Meeder Asset Management Inc. boosted its holdings in shares of Synopsys by 33.3% in the first quarter. Meeder Asset Management Inc. now owns 104 shares of the semiconductor company's stock valued at $45,000 after buying an additional 26 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on SNPS shares. Morgan Stanley reiterated an "overweight" rating and issued a $715.00 price target (up previously from $540.00) on shares of Synopsys in a report on Monday, August 11th. Stifel Nicolaus set a $550.00 price target on shares of Synopsys in a report on Monday, April 28th. Needham & Company LLC restated a "buy" rating and set a $660.00 target price (up previously from $650.00) on shares of Synopsys in a report on Tuesday, July 15th. Piper Sandler increased their target price on shares of Synopsys from $615.00 to $660.00 and gave the stock an "overweight" rating in a report on Monday, July 21st. Finally, KeyCorp increased their target price on shares of Synopsys from $540.00 to $610.00 and gave the stock an "overweight" rating in a report on Thursday, July 10th. Twelve investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $626.79.

Insider Buying and Selling at Synopsys

In other news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $457.93, for a total value of $5,204,832.38. Following the transaction, the chief executive officer directly owned 71,589 shares of the company's stock, valued at $32,782,750.77. This represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shelagh Glaser sold 7,310 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the completion of the transaction, the chief financial officer directly owned 15,291 shares in the company, valued at $7,427,144.52. The trade was a 32.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,686 shares of company stock worth $13,001,048 over the last quarter. 0.62% of the stock is currently owned by insiders.

Synopsys Stock Performance

SNPS stock traded up $8.35 during trading hours on Friday, reaching $606.52. The stock had a trading volume of 863,153 shares, compared to its average volume of 1,421,519. The stock has a market capitalization of $94.11 billion, a PE ratio of 43.79, a price-to-earnings-growth ratio of 3.95 and a beta of 1.15. The company has a debt-to-equity ratio of 1.01, a current ratio of 7.02 and a quick ratio of 6.85. The stock has a 50-day simple moving average of $567.73 and a 200 day simple moving average of $500.38. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, beating analysts' consensus estimates of $3.40 by $0.27. The firm had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.60 billion. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The company's revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter last year, the company posted $3.00 earnings per share. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. Analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.